SAHEBJAM, Solmaz
$55,000.00 CAD
≈ 9 months of average Canadian pay
- Department
- Canadian Institutes of Health Research
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2011-2012
- Agreement period
- August 1, 2011 – July 31, 2013
- Reference
- cihr-irsc:236-2011-2012-Q1-00908
Published purpose
Evaluating the anti-tumor activity of a dual IGF-1R and IR inhibitor (OSI-906) in genomically characterized human breast cancer (BC) xenograft models.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions